BackCogent Biosciences Overview

Cogent Biosciences Total Liabilities

Track Cogent Biosciences's total liabilities ($300M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$295.31M
↑ 355.71% YoYΔ $230.51M vs prior year quarter

Peer average

Loading

Cogent Biosciences Total Liabilities History

Loading

Cogent Biosciences vs. peers: Total Liabilities Comparison

Loading

Cogent Biosciences Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Cogent Biosciences (COGT) FAQ

As of the most recent data (March 2026), COGT shows a total liabilities of $300M. That compares with $65M in the prior-year period — up 355.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, COGT's total liabilities is now $300M (was $65M) — a 355.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Cogent Biosciences is outperforming or lagging.

Tracking COGT's total liabilities over time shows whether Cogent Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $300M That compares with $65M in the prior-year period — up 355.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Cogent Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $300M) with ownership activity and broader fundamentals.

Cogent Biosciences's total liabilities is $300M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.